Liver disease in haemophilia

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.

Haemophilia : the official journal of the World Federation of Hemophilia·2018

A post-marketing safety and efficacy assessment of a monoclonal antibody purified high-purity factor VIII concentrate.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Didanosine treatment of haemophilic patients infected with HIV.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Development of a World Federation of Hemophilia External Quality Assessment Scheme: results of a pilot study.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Stability of coagulation proteins in lyophilized plasma.

International journal of laboratory hematology·2014

Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.

Haemophilia : the official journal of the World Federation of Hemophilia·2009

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first-time blood donors.

Transfusion·2026

Association between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.

Journal of nephrology·2026

Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke.

Future cardiology·2026

Impact of HLA-B leader matching on clinical outcomes of haploidentical hematopoietic stem cell transplantation in adult patients with acute leukemia, a retrospective cohort study.

Annals of medicine and surgery (2012)·2026

Tgfbr3 is required for the long-term maintenance of self-renewal potential in murine hematopoietic stem cells.

Blood science (Baltimore, Md.)·2026

Sickle red blood cell/Siglec-9 interactions contribute to neutrophil activation in SCD and are associated with survival.

Blood. Red cells & iron·2026

Related Experiment Videos

Liver disease in haemophilia

Related Concept Videos

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.

A post-marketing safety and efficacy assessment of a monoclonal antibody purified high-purity factor VIII concentrate.

Didanosine treatment of haemophilic patients infected with HIV.

Development of a World Federation of Hemophilia External Quality Assessment Scheme: results of a pilot study.

Stability of coagulation proteins in lyophilized plasma.

Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Three novel RHD variant alleles were identified through routine molecular screening of serologically RH1 negative first-time blood donors.

Association between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.

Thrombophilias associated with patent foramen ovale (PFO) in patients after an episode of cryptogenic stroke.

Impact of HLA-B leader matching on clinical outcomes of haploidentical hematopoietic stem cell transplantation in adult patients with acute leukemia, a retrospective cohort study.

Tgfbr3 is required for the long-term maintenance of self-renewal potential in murine hematopoietic stem cells.

Sickle red blood cell/Siglec-9 interactions contribute to neutrophil activation in SCD and are associated with survival.

Related Experiment Videos

Liver disease in haemophilia

Related Concept Videos

Related Articles